OPC 25 OPC 25 Pill - blue & pink capsule/oblong, 19mm
Generic Name: opicapone
Pill with imprint OPC 25 OPC 25 is Blue & Pink, Capsule/Oblong and has been identified as Ongentys 25 mg. It is supplied by Neurocrine Biosciences, Inc.
Ongentys is used in the treatment of Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Ongentys 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for OPC 25 OPC 25
Ongentys
- Generic Name
- opicapone
- Imprint
- OPC 25 OPC 25
- Strength
- 25 mg
- Color
- Blue & Pink
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Neurocrine Biosciences, Inc.
- National Drug Code (NDC)
- 70370-3025
See also:
Sinemet
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle stiffness, tremors ...
Cogentin
Cogentin is used for extrapyramidal reaction, parkinson's disease
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Requip
Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors and muscle ...
Mirapex
Mirapex (pramipexole) treats the symptoms of Parkinson's disease and is also used to treat Restless ...
Rytary
Rytary is used to treat symptoms of Parkinson's disease and parkinsonism that may follow carbon ...
Azilect
Azilect (rasagiline) is used to treat the symptoms of Parkinson's disease. Learn about side ...
Crexont
Crexont (carbidopa and levodopa) is an extended-release capsule that may be used to treat symptoms ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
More about Ongentys (opicapone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.